Cargando…
Predictive biomarkers and potential drug combinations of epi-drugs in cancer therapy
Epigenetics studies heritable genomic modifications that occur with the participation of epigenetic modifying enzymes but without alterations of the nucleotide structure. Small-molecule inhibitors of these epigenetic modifying enzymes are known as epigenetic drugs (epi-drugs), which can cause progra...
Autores principales: | Yang, Tianshu, Yang, Yunkai, Wang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130364/ https://www.ncbi.nlm.nih.gov/pubmed/34001246 http://dx.doi.org/10.1186/s13148-021-01098-2 |
Ejemplares similares
-
Epi‐immunotherapy for cancers: rationales of epi‐drugs in combination with immunotherapy and advances in clinical trials
por: Xu, Yang, et al.
Publicado: (2022) -
Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy
por: Lu, Yuanjun, et al.
Publicado: (2020) -
Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy
por: Mazzone, Roberta, et al.
Publicado: (2017) -
Epi-Drugs in Heart Failure
por: Gorica, Era, et al.
Publicado: (2022) -
A Novel Epi-drug Therapy Based on the Suppression of BET Family Epigenetic Readers
por: Shin, Dong-Guk, et al.
Publicado: (2017)